Respiratory medicine clinical quality indicators

Find out how we are doing in respiratory medicine using the links below. More information on how we choose our indicators can be found by clicking on the link on the right hand side.

 

Re-admission in patients with COPD

This is the clinical quality indicator for the proportion of patients who are re-admitted with respiratory disease within 28 days of discharge.

Rationale

Re-admission reflects a range of hospital-based and community-based parameters of care. Rates are available nationally.

Our objectives

We aim to reduce our 90 day re-admission rate to below the national average of 34%, and our 28 day re-admission rate to below 20%.

Our performance

 

Specialist respiratory care

This is the clinical quality indicator for the proportion of patients with a primary diagnosis of chronic obstructive pulmonary disease, asthma or pneumothorax who are treated by our team of specialist respiratory physicians.

Rationale

Published evidence and national guidelines suggest that better clinical outcomes are achieved when specialist respiratory physicians are involved in the care of patients with these conditions.

Our objectives

We aim for our specialist respiratory physicians to be involved in the care of at least 70% of patients with these conditions.

Current performance

 

Tuberculosis

This is the clinical quality indicator for the proportion of patients assessed for risk indicators:

  • homelessness
  • alcohol use
  • mental health issues
  • other complex social need

These assesments are often associated with non-completion of therapy.

Rationale

Rates of tuberculosis in UK are increasing with 40% of sufferers living in London.

Drug resistance is more prevalent in London, as a result of higher rates of non-adherence to and non-completion of treatment.

Routine risk assessment will allow a greater understanding of the reasons for non-adherence and provide opportunities for effective intervention with important public health benefits.

Our objectives

We aim to assess more than 90% of our patients for risk of TB.

Current performance

Awaiting information.